Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
High street bank's acquisition of workplace pension provider nets 46% gain for Augmentum, a backer of early-stage financial services disrupters whose shares are in urgent need of an uplift themselves on a 30% discount.
Shires Income positions itself as a key player in Abrdn Smaller Companies Income's search for a merger partner, disclosing recent talks with its stable mate.
Co-manager John Yakas and chairman Robert Lyprianou are stepping back from London's only listed financials fund.
It is ‘show-and-tell time’ for many investment companies trading at discounts of more than 20% below net asset value.
Our columnist considers topping up his position in Pershing Square after Bill Ackman tells investors he is serious about solving the US equity fund’s 35% discount.
Shares in £68m portfolio leap after its board launches a strategic review, concluding the trust is too small to have a viable future.
In an unusual development, SV Health, fund manager of the £300m International Biotechnology Trust serves 12-month notice, saying it wants to focus on its healthcare venture business.
SV Health, manager of the £300m International Biotechnology Trust, serves 12-month notice, saying it wants to focus on its healthcare venture business.
SV Health, manager of the £300m International Biotechnology Trust, serves 12-month notice, saying it wants to focus on its healthcare venture business.
Board of £300m International Biotechnology Trust consults big shareholders after fund manager SV Health serves 12-month notice, saying it wants to focus on its healthcare venture business.
Share issue of £1.3bn Brevan Howard hedge fund was mainly backed by institutional and professional investors, but private investors subscribed for £66m of sterling shares.
Brevan Howard hedge fund lifts assets by a quarter after institutional and professional investors take advantage of keenly-priced share issue from the all-weather performer.
Developed by Moore-Wilson
Follow us
